Evidence map›Paper›PMID 22034172›Full record

ArticleArthritis and rheumatism2012

Felty's syndrome autoantibodies bind to deiminated histones and neutrophil extracellular chromatin traps.

Nishant Dwivedi, Jagriti Upadhyay, Indira Neeli, Salar Khan, Debendra Pattanaik, Linda Myers, Kyriakos A Kirou, Bernhard Hellmich, Bryan Knuckley, Paul R Thompson and 4 more

Open access · greenAbstract read
In one paragraph

Article in Arthritis and rheumatism, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
11.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 122 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Felty's syndrome.Frontiers in medicine · 2023
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Chronic neutropenia in LGL leukemia and rheumatoid arthritis.Hematology. American Society of Hematology. Education Program · 2017
    Review
  19. Article
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 2 countries.

Nishant DwivediUniversity of Tennessee Health Science Center, Memphis, TN 38163, USA.
Jagriti Upadhyay
Indira Neeli
Salar Khan
Debendra Pattanaik
Linda Myers
Kyriakos A Kirou
Bernhard Hellmich
Bryan Knuckley
Paul R Thompson
Mary K Crow
Ted R Mikuls
Elena Csernok
Marko Radic
University of Tennessee Health Science Center · USHospital for Special Surgery · USScripps Research Institute · USUniversity of Lübeck · DEUniversity of Nebraska Medical Center · USUniversity of South Carolina · USUniversity of Tübingen · DE

Funding

Haloacetamidine based inactivators of Protein Arginine Deiminase 4R01GM079357 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI THOMPSON, PAUL R · 2007 to 2016
$3.3M
NIGMS NIH HHS R01 GM079357
6 · The paper itself

Abstract

objectiveTo test the hypothesis that autoantigen modifications by peptidylarginine deiminase type 4 (PAD-4) increase immunoreactivity.

methodsWe assembled sera from patients with systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), Felty's syndrome (FS), and antineutrophil cytoplasmic antibody-associated vasculitides (AAVs), as well as sera from control subjects without autoimmune diseases. The sera were tested for binding to activated neutrophils, deiminated histones, and neutrophil extracellular chromatin traps (NETs). IgG binding to lipopolysaccharide-activated neutrophils was assessed with confocal microscopy, and binding to in vitro-deiminated histones was measured using enzyme-linked immunosorbent assay (ELISA) and Western blotting. In addition, we quantitated histone deimination in freshly isolated neutrophils from the blood of patients and control subjects.

resultsIncreased IgG reactivity with activated neutrophils, particularly binding to NETs, was paralleled by preferential binding to deiminated histones over nondeiminated histones by ELISA in a majority of sera from FS patients but only in a minority of sera from SLE and RA patients. Immunoblotting revealed autoantibody preference for deiminated histones H3, H4, and H2A in most FS patients and in a subset of SLE and RA patients. In patients with AAVs, serum IgG preferentially bound nondeiminated histones over deiminated histones. Increased levels of deiminated histones were detected in neutrophils from RA patients.

conclusionCirculating autoantibodies in FS are preferentially directed against PAD-4-deiminated histones and bind to activated neutrophils and NETs. Thus, increased reactivity with modified autoantigens in FS implies a direct contribution of neutrophil activation and the production of NET-associated nuclear autoantigens in the initiation or progression of FS.

Indexed as

AdolescentAdultAgedAged, 80 and overAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisArthritis, RheumatoidAutoantibodiesAutoantigensFelty SyndromeFemaleHistonesHumansLupus Erythematosus, SystemicMaleMiddle AgedNeutrophilsAutoantibodiesAutoantigensHistones

Identifiers

PMID22034172
PMCPMC4729190
OpenAlexW2006560462

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.